Close Menu
Global News HQ
    What's Hot

    Dime Community Bancshares: Preferred Shares Offer Better Income And Return (NASDAQ:DCOM)

    July 2, 2025

    ICEBlock climbs to the top of the App Store charts after officials slam it

    July 2, 2025

    USPS Implements Phase Two of Service Standard Changes

    July 2, 2025
    Recent Posts
    • Dime Community Bancshares: Preferred Shares Offer Better Income And Return (NASDAQ:DCOM)
    • ICEBlock climbs to the top of the App Store charts after officials slam it
    • USPS Implements Phase Two of Service Standard Changes
    • Why showing your work is the new mark of great design
    • Bowers & Wilkins and Abbey Road Studios Just Dropped a Pair of Limited-Edition Loudspeakers
    Facebook X (Twitter) Instagram YouTube TikTok
    Trending
    • Dime Community Bancshares: Preferred Shares Offer Better Income And Return (NASDAQ:DCOM)
    • ICEBlock climbs to the top of the App Store charts after officials slam it
    • USPS Implements Phase Two of Service Standard Changes
    • Why showing your work is the new mark of great design
    • Bowers & Wilkins and Abbey Road Studios Just Dropped a Pair of Limited-Edition Loudspeakers
    • Never Put This Item Down the Drain, a Cleaner Warns—It Can Harm Your Sink and Plumbing
    • Americans Are Spending More on Luxe Jewelry While Decreasing Spending on Other Goods: Report
    • One in Five Law Firms Hit by Cyberattacks Over Past 12 Months | Law.com
    Global News HQ
    • Technology & Gadgets
    • Travel & Tourism (Luxury)
    • Health & Wellness (Specialized)
    • Home Improvement & Remodeling
    • Luxury Goods & Services
    • Home
    • Finance & Investment
    • Insurance
    • Legal
    • Real Estate
    • More
      • Cryptocurrency & Blockchain
      • E-commerce & Retail
      • Business & Entrepreneurship
      • Automotive (Car Deals & Maintenance)
    Global News HQ
    Home - Finance & Investment - Why AstraZeneca Stock Topped the Market on Tuesday | The Motley Fool
    Finance & Investment

    Why AstraZeneca Stock Topped the Market on Tuesday | The Motley Fool

    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Why AstraZeneca Stock Topped the Market on Tuesday | The Motley Fool
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Trading in AstraZeneca‘s (AZN 2.26%) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a U.S. exchange. Investors clearly liked that idea, as they bid those ADSes up by more than 2% that trading session. With that rise, it did better than the S&P 500 (^GSPC -0.11%), which closed the day marginally (0.1%) lower.

    Bye-bye Britain?

    That morning, U.K. newspaper The Times published an article stating that AstraZeneca CEO Pascal Soriot aims to move the company’s stock market listing onto our shores (ADSes are certificates conferring ownership of a stock, not the stock itself).

    Image source: Getty Images.

    Citing unidentified multiple sources, the newspaper wrote that Soriot might also be mulling a move of AstraZeneca’s headquarters from the U.K. to the U.S.

    Currently, the global healthcare company is a component of the FTSE 100, considered by many to be the most important U.K. stock index.

    According to The Times‘ reporting, the chief executive is “known to be deeply frustrated with the U.K.’s operating environment.” The newspaper added that he has publicly expressed concern about what he perceives to be a decline in European competitiveness against the U.S. and China. The pair happens to be the company’s two largest markets.

    Neither Soriot nor AstraZeneca has yet officially commented on the article.

    Land of opportunity

    Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market listing and even the headquarters here. It’s unclear (at least for now) how much this might affect the company’s fundamentals and operations, but as a concept, it’s a good idea.

    Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy.

    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous Article‘Like Cattle at a Sale Barn’: Four Minnesota Firms in $1.51B Syngenta Settlement Accused of Malpractice | Law.com
    Next Article Elon Musk’s Companies at Risk as He Reignites Feud With Trump

    Related Posts

    Dime Community Bancshares: Preferred Shares Offer Better Income And Return (NASDAQ:DCOM)

    July 2, 2025

    Labour guts UK welfare reforms in Starmer U-turn

    July 1, 2025

    10 Best Free (or Cheap) Online Classes for Seniors and Retirees

    July 1, 2025

    Wallenius Wilhelmsen: Upside Potential With High Risk (WILWY)

    July 1, 2025
    Leave A Reply Cancel Reply

    ads
    Don't Miss
    Finance & Investment
    2 Mins Read

    Dime Community Bancshares: Preferred Shares Offer Better Income And Return (NASDAQ:DCOM)

    This article was written byFollowAbout My Writing: I am currently focused on income investing through…

    ICEBlock climbs to the top of the App Store charts after officials slam it

    July 2, 2025

    USPS Implements Phase Two of Service Standard Changes

    July 2, 2025

    Why showing your work is the new mark of great design

    July 2, 2025
    Top
    Finance & Investment
    2 Mins Read

    Dime Community Bancshares: Preferred Shares Offer Better Income And Return (NASDAQ:DCOM)

    This article was written byFollowAbout My Writing: I am currently focused on income investing through…

    ICEBlock climbs to the top of the App Store charts after officials slam it

    July 2, 2025

    USPS Implements Phase Two of Service Standard Changes

    July 2, 2025
    Our Picks
    Finance & Investment
    2 Mins Read

    Dime Community Bancshares: Preferred Shares Offer Better Income And Return (NASDAQ:DCOM)

    This article was written byFollowAbout My Writing: I am currently focused on income investing through…

    Technology & Gadgets
    3 Mins Read

    ICEBlock climbs to the top of the App Store charts after officials slam it

    US government officials have condemned ICEBlock and CNN’s recent coverage of it, leading to more people…

    Pages
    • About Us
    • Contact Us
    • Disclaimer
    • Homepage
    • Privacy Policy
    Facebook X (Twitter) Instagram YouTube TikTok
    • Home
    © 2025 Global News HQ .

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version